Acomplia Could Help Those Suffering From Alcoholic Livers

the best cure for an alcoholic fatty liver is quite simply to stop drinking

More research done with the Acomplia weight loss medication shows that as well as helping people to lose weight it could also be beneficial for preventing the development of what is called an “alcoholic fatty liver”. The study that was done in America by researchers working for the National Institute on Alcohol Abuse and Alcoholism saw that when laboratory mice were given doses of the Acomplia drug they became resistant to the build up of fat due to alcohol in the liver. A build up of fat in the liver due to alcohol abuse can lead to more serious liver problems over the long term.

Sanofi Aventis have not only researched the Acomplia weight loss medication for treatment of obesity but also are keen to show that it can help people suffering from obesity related illnesses. The Acomplia medication is said to help diabetics and it also can lower cholesterol levels in some patients. If Sanofi Aventis can show that the Acomplia drug is not just purely for obesity but for a host of other applications they could greatly improve their sales. Insurance companies are also more likely to pay up for the use of the drug if it has other uses other than just for obesity.

It should be remembered however that the best cure for an alcoholic fatty liver is quite simply to stop drinking and that while taking medication may help you slightly in the short term if you do not stop drinking you will eventually damage your health irreparably. The scientists involved in this research said that more work needs to be done with the Acomplia weight loss drug to show and examine all of its benefits.

Acomplia is sold in the United Kingdom as a prescription medication to help obese people lose weight and can also be prescribed to overweight people who are suffering from an illness related to their weight.